Susquehanna International Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.15M | Sell |
39,800
-15,600
| -28% | -$870K | ﹤0.01% | 6004 |
|
|
2025
Q4 | $3.1M | Buy |
55,400
+43,400
| +362% | +$2.25M | ﹤0.01% | 4821 |
|
|
2025
Q3 | $575K | Sell |
12,000
-2,100
| -15% | -$93.9K | ﹤0.01% | 8653 |
|
|
2025
Q2 | $572K | Buy |
14,100
+4,100
| +41% | +$165K | ﹤0.01% | 8858 |
|
|
2025
Q1 | $438K | Sell |
10,000
-6,500
| -39% | -$287K | ﹤0.01% | 9192 |
|
|
2024
Q4 | $709K | Sell |
16,500
-700
| -4% | -$31.8K | ﹤0.01% | 7794 |
|
|
2024
Q3 | $763K | Buy |
17,200
+5,400
| +46% | +$231K | ﹤0.01% | 7449 |
|
|
2024
Q2 | $469K | Sell |
11,800
-3,800
| -24% | -$154K | ﹤0.01% | 8418 |
|
|
2024
Q1 | $673K | Buy |
15,600
+600
| +4% | +$25.9K | ﹤0.01% | 7790 |
|
|
2023
Q4 | $624K | Buy |
15,000
+9,900
| +194% | +$375K | ﹤0.01% | 8122 |
|
|
2023
Q3 | $203K | Buy |
+5,100
| New | +$216K | ﹤0.01% | 10203 |
|
|
2023
Q2 | – | Sell |
-5,700
| Closed | -$234K | – | 13291 |
|
|
2023
Q1 | $234K | Sell |
5,700
-13,000
| -70% | -$546K | ﹤0.01% | 10260 |
|
|
2022
Q4 | $766K | Buy |
+18,700
| New | +$778K | ﹤0.01% | 6766 |
|
|
2021
Q2 | – | Sell |
-4,400
| Closed | -$222K | – | 13363 |
|
|
2021
Q1 | $222K | Sell |
4,400
-39,300
| -90% | -$2.09M | ﹤0.01% | 11215 |
|
|
2020
Q4 | $2.27M | Sell |
43,700
-6,900
| -14% | -$330K | ﹤0.01% | 4825 |
|
|
2020
Q3 | $2.2M | Sell |
50,600
-26,800
| -35% | -$1.17M | ﹤0.01% | 4437 |
|
|
2020
Q2 | $3.33M | Sell |
77,400
-21,400
| -22% | -$884K | ﹤0.01% | 3629 |
|
|
2020
Q1 | $3.56M | Buy |
98,800
+13,500
| +16% | +$575K | ﹤0.01% | 3029 |
|
|
2019
Q4 | $3.9M | Buy |
85,300
+77,000
| +928% | +$3.05M | ﹤0.01% | 3330 |
|
|
2019
Q3 | $295K | Buy |
+8,300
| New | +$309K | ﹤0.01% | 8336 |
|
|
2019
Q2 | – | Sell |
-23,600
| Closed | -$981K | – | 10929 |
|
|
2019
Q1 | $981K | Sell |
23,600
-500
| -2% | -$20.3K | ﹤0.01% | 5085 |
|
|
2018
Q4 | $883K | Buy |
24,100
+600
| +3% | +$25.6K | ﹤0.01% | 4921 |
|
|
2018
Q3 | $1.14M | Buy |
+23,500
| New | +$1.11M | ﹤0.01% | 4967 |
|
|
2017
Q3 | – | Sell |
-11,400
| Closed | -$491K | – | 9747 |
|
|
2017
Q2 | $491K | Sell |
11,400
-8,700
| -43% | -$367K | ﹤0.01% | 6679 |
|
|
2017
Q1 | $841K | Buy |
+20,100
| New | +$819K | ﹤0.01% | 5492 |
|
|
2016
Q1 | – | Sell |
-10,100
| Closed | -$517K | – | 9761 |
|
|
2015
Q4 | $517K | Sell |
10,100
-9,600
| -49% | -$489K | ﹤0.01% | 6705 |
|
|
2015
Q3 | $924K | Sell |
19,700
-700
| -3% | -$42.2K | ﹤0.01% | 5925 |
|
|
2015
Q2 | $1.27M | Buy |
20,400
+10,800
| +113% | +$673K | ﹤0.01% | 5683 |
|
|
2015
Q1 | $593K | Buy |
9,600
+400
| +4% | +$23.7K | ﹤0.01% | 6783 |
|
|
2014
Q4 | $497K | Buy |
9,200
+800
| +10% | +$43.7K | ﹤0.01% | 7217 |
|
|
2014
Q3 | $445K | Buy |
+8,400
| New | +$427K | ﹤0.01% | 7416 |
|
Other funds holding XPH
KWM
FCBT
Susquehanna International Group's XPH Position: Q1 2026 in Review
Susquehanna International Group increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 127% in Q1 2026, buying an estimated $1.52M and bringing the position to 48,834 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #5543.
Susquehanna International Group first reported a position in XPH in Q2 2013 and has held it in 47 quarters since. The position peaked at $19.2M in Q3 2015. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.
- Susquehanna International Group held 48,834 shares of State Street SPDR S&P Pharmaceuticals ETF worth $2.64M as of Q1 2026.
- Susquehanna International Group bought 27,337 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $1.52M.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5543 holding.
- Susquehanna International Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $19.2M in Q3 2015.
- 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.